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bers to exert their cytoprotective effects which may be mediated through a
mechanism involving Kir 6.1-containing mitochondrial potassium channels,
which we have also shown to exist in this cell line. The observation that
these cells express both CRFR1 and CRFR2 is novel in that CRFR1 are largely
conﬁned to the central nervous system in humans, but would explain the
greater potency of Ucn I in chondroprotection as this peptide binds to both
CRFR1 and CRFR2 whilst Ucn II and Ucn III are selective CRFR2 ligands. The
demonstration that Ucn treatment results in p42/44 MAPK activation also
suggest the involvement of other cytoprotective mechanisms (e.g. cAMP
and PKA modulated responses) in Ucn mediated chondroprotection.
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A PEPTIDYL-GLUCOSAMINE DERIVATIVE AFFECTS IKKalpha KINASE
ACTIVITY IN HUMAN CHONDROCYTES
A. Scotto d’Abusco, L. Politi, P. Santini, D. Stoppoloni, R. Scandurra
Univ. of Roma, Roma, Italy
Purpose: NF-kappaB transcription factor regulates several cell signaling
pathways, such as differentiation and inﬂammation, which are both altered
in osteoarthritis. IKKalpha and IKKbeta are kinases involved in the activa-
tion of the NF-kappaB transcription factor. The aim of the present study
was to determine the effects of glucosamine, which is administered in the
treatment of osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-
deoxy-beta-D-glucose derivative (glucosamine-derivative) on IKK kinases
and, consequently, on NF-kappaB activation in human chondrocytes.
Methods: The human chondrosarcoma cell line HTB-94 and human pri-
mary chondrocytes were stimulated with TNFalpha after pre-treatment
with glucosamine or glucosamine-derivative. Gene mRNA expression level
was evaluated by Real Time-PCR. IkappaBalpha phosphorylation and p65
nuclear translocation were analyzed by Western blotting, IKKalpha nuclear
re-localization was investigated by immunocytochemistry and by Western
blotting. IKK kinase activity was studied by in vitro kinase assay, using IKK
complex immunoprecipitated by cells or using recombinant IKkalpha and
IKKbeta.
Results: After TNFalpha stimulation, the mRNA expression level of some
of the genes under NF-kappaB control, such as IL-6 and IL-8, increased,
while treatment with glucosamine and glucosamine-derivative reverted the
effect. We investigated the possibility that ﬂucosamine and its derivative
inhibit IKK kinase activity and found that glucosamine-derivative inhibits
the IKKalpha kinase activity, whereas glucosamine does not. Interestingly,
both molecules inhibit IKKalpha nuclear translocation.
Conclusions: Our results demonstrate that glucosamine and its peptidyl-
derivative can interfere with NF-kappaB signaling pathway by inhibit-
ing IKKalpha activity in human chondrocytes. However, the mechanism
of action of the two molecules is not completely overlapping. While
glucosamine-derivative can both speciﬁcally inhibit the IKKalpha kinase
activity and IKKalpha nuclear translocation, glucosamine only acts on
IKKalpha nuclear re-localization.
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A FULL-DEPTH CARTILAGE EXPLANTS CULTUREMODEL FOR
INVESTIGATING CHONDROCYTES HYPERTROPHIC IN OSTEOARTHRITIS
P. Chen, K. Andreassen, K. Henriksen, M.A. Karsdal, A.-C. Bay-Jensen
NordicbioSci. A/S, Herlev, Denmark
Purpose: Chondrocytes become hypertrophic, which leads to calciﬁ-
cation of cartilage matrix. This is a pathological event in the early
phase of osteoarthritis (OA). We are interested in three subpopulations:
pre-hypertrophic chondrocytes, hypertrophic chondrocytes and mature
hypertrophic chondrocytes, which are undergoing apoptosis. These three
subpopulations of hypertrophic chondrocytes play different role in patho-
genesis of OA. The aim of our work was to develop and validate an ex vivo
model, which includes the different subpopulations of chondrocytes, and in
which hypertrophic chondrocytes could be induced by adding appropriate
factors. This model was supposed to be used for examination of cartilage
changes related to morphological changes. Thus, aiding the understanding
of the role of hypertrophy chondrocytes in OA pathogenesis.
Methods: Full depth cartilage explants (from superﬁcial to calciﬁed carti-
lage) were isolated from bovine femoral condyle and cultured for 21 days
with different stimulators: 1) TNF-α [20ng/ml] + Oncostatin M [10ng/ml],
2) IGF-1 [100ng/ml], 3) bFGF [50ng/ml], and 4) BMP-2[100ng/ml]. Super-
natants were collected every two or three days. Safranin O/Fast Green
(SaFO) and Tuludine Blue (TuB) staining were used to distinguish the mor-
phology of the explants. Collagen type II turnover was measure by PIINP
(formation) and CIIMB (degradation) assay. As markers of hypertrophy
chondrocytes, expression of Indian hedgehog, type X collagen, ALP and
MMP-13 were evaluated using reverse transcription followed by real-time
polymerase chain reaction (PCR) at day 14.
Results: Alamarblue data showed that all explants were alive throughout
the 21 days. Both IGF-1 and bFGF groups had enlarged cells at day 7 and 14
(TuB and SaFO stainings). CIIMB and PIINP assay results suggested that both
IGF-1 and bFGF had signiﬁcant (p<0.05) collagen type II degradation and
formation at day 7, but not day 14 and 21. BMP-2 increased signiﬁcantly
expression of Ihh, COL X, ALP and MMP-13 at day 14 (p<0.0001) compared
with W/O. bFGF increased expression of Ihh and MMP-13 but not signiﬁ-
cantly, and the expression of COL X and ALP of bFGF stimulated group were
lower than W/O. The increased expression of hypertrophy chondrocytes
markers conﬁrmed that BMP-2 could induce chondrocytes hypertrophic in
FDC model.
Conclusions: We have developed an explants culture models that include
all the different layers of the articular cartilage and were able to induce
hypertrophy by stimulating with BMP-2. We could detect the gene expres-
sion of markers at different subpopulations of chondrocytes in the ex vivo
culture model. We speculate that this model could be used as an important
ex vivo model for simulating cartilage degenerative diseases and thereby
for investigating the effect of different drug candidates.
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GLUCOCORTICOIDS ATTENUATE BONE TURNOVER, BUT DO NOT APPEAR
TO AFFECT CHONDROCYTESIN VITRO
K. Henriksen, K.V. Andreassen, S.H. Madsen, M.A. Karsdal, A.-C. Bay-Jensen
Nordic BioSci. A/S, Herlev, Denmark
Purpose: Glucocorticoids are known to attenuate bone formation in vivo
leading to decreased bone volume and increased risk of fractures, whereas
effects on the joint tissue are not known. This study aimed at characterizing
the effect of glucocorticoids on osteoclasts and osteoblasts, as well as the
closely related chondrocytes.
Methods: We used CD14+ monocytes cultured in the presence of M-CSF
and RANKL to investigate the effect of glucocorticoids on different osteo-
clastic parameters. We measured TRACP activity and Calcium release as
indices of osteoclast number and activity. 2T3 preosteoblastic cells we used
to characterize the effects of glucocorticoids on bone formation, either
in the presence or absence of BMP-2. Alizarin Red was used to measure
nodule formation, ALP activity as an indicator of osteoblastogenesis. Bovine
full depth cartilage explants were cultured with or without TNF-a, OSM and
IGF-1 to characterize the effects of glucocorticoids on cartilage turnover.
Collagen type II degradation was measured by CIIMB, and aggrecan degra-
dation by 373-G1. Safranin O staining was used to investigate proteoglycan
content in sections of the cultured explants. In all assays Alamar Blue was
used as an indicator of viability.
Results: DEX and PRED dose-dependently inhibited osteoclastogenesis by
promoting cell death. For mature osteoclasts, low doses of GLUC induced
bone resorption short term, whereas high doses and continued exposure
led to osteoclast death. In osteoblasts glucocorticoids induced cell death in
the non-stimulated cells. For BMP-2 stimulated cells; we found that GLUCs
augmented nodule formation, while still reducing cell viability. In cartilage
we found that GLUCs were unable to alter cartilage turnover, although at
high concentrations a minor reduction in safranin O staining intensity was
observed.
Conclusions: In summary, using highly robust models of bone and car-
tilage turnover, we have shown that the effects of glucocorticoids on
bone depend very much in the cell targeted, i.e. activated osteoblasts are
further activated by GLUC, whereas non-activated cells undergo cell death.
In cartilage no apparent effects were observed, indicating that cartilage
may not possess glucocorticoid receptors, or that these are not active. We
believe that these model systems are highly relevant for the continued
development of glucocorticoid analogues without the detrimental effect on
bone
